(b) Proportion of patients with SBM within 24 hours (relative risk and corresponding 95% Crls)
| Elobixibat 10 mg | ||||
| 1.374 (0.529, 3.839) | Linaclotide 0.5 mg | |||
| 0.889 (0.390, 2.035) | 0.645 (0.218, 1.800) | Lubiprostone 48 μg | ||
| 1.149 (0.433, 3.302) | 0.836 (0.247, 2.829) | 1.295 (0.453, 3.910) | Lactulose 26 g | |
| 2.051 (1.277, 3.579) | 1.493 (0.640, 3.516) | 2.317 (1.259, 4.542) | 1.789 (0.749, 4.308) | Placebo |